Cargando…

A Mucosal Subunit Vaccine Protects against Lethal Respiratory Infection with Francisella tularensis LVS

Francisella tularensis (FT) is a highly virulent pathogen for humans and other mammals. Severe morbidity and mortality is associated with respiratory FT infection and there are concerns about intentional dissemination of this organism. Therefore, FT has been designated a category A biothreat agent a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashtekar, Amit R., Katz, Jannet, Xu, Qingan, Michalek, Suzanne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508931/ https://www.ncbi.nlm.nih.gov/pubmed/23209745 http://dx.doi.org/10.1371/journal.pone.0050460

Ejemplares similares

Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection
por: Mohapatra, Saroj K, et al.
Publicado: (2010)

IKKβ in Myeloid Cells Controls the Host Response to Lethal and Sublethal Francisella tularensis LVS Infection
por: Samaniego, Sylvia, et al.
Publicado: (2013)

The capBCA Locus is Required for Intracellular Growth of Francisella tularensis LVS
por: Su, Jingliang, et al.
Publicado: (2011)

The role of MglA for adaptation to oxidative stress of Francisella tularensis LVS
por: Honn, Marie, et al.
Publicado: (2012)

Role of mTOR Downstream Effector Signaling Molecules in Francisella Tularensis Internalization by Murine Macrophages
por: Edwards, Michael W., et al.
Publicado: (2013)

Evolution of Antibiotic Resistance in Surrogates of Francisella tularensis (LVS and Francisella novicida): Effects on Biofilm Formation and Fitness
por: Biot, Fabrice V., et al.
Publicado: (2020)

Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate
por: Kim, Eun-Ju, et al.
Publicado: (2008)

Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages
por: Bradford, Mary Katherine, et al.
Publicado: (2020)

Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge
por: McCormick, Alison A., et al.
Publicado: (2018)

Francisella tularensis LVS Surface and Membrane Proteins as Targets of Effective Post-Exposure Immunization for Tularemia
por: Chandler, Jeffrey C., et al.
Publicado: (2014)

Characterization of Inner and Outer Membrane Proteins from Francisella tularensis Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates
por: Post, Deborah M. B., et al.
Publicado: (2017)

Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections
por: Robinson, Cory M, et al.
Publicado: (2015)

Immunoproteomics Analysis of the Murine Antibody Response to Vaccination with an Improved Francisella tularensis Live Vaccine Strain (LVS)
por: Twine, Susan M., et al.
Publicado: (2010)

IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected mice
por: Mittereder, Lara R., et al.
Publicado: (2023)

Protective Immunity against Lethal F. tularensis holarctica LVS Provided by Vaccination with Selected Novel CD8(+) T Cell Epitopes
por: Rotem, Shahar, et al.
Publicado: (2014)

The Francisella tularensis LVS ΔpdpC mutant exhibits a unique phenotype during intracellular infection
por: Lindgren, Marie, et al.
Publicado: (2013)

Outer membrane vesicle-associated lipase FtlA enhances cellular invasion and virulence in Francisella tularensis LVS
por: Chen, Fei, et al.
Publicado: (2017)

Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity
por: Kurtz, Sherry L., et al.
Publicado: (2021)

Deletion Mutants of Francisella Phagosomal Transporters FptA and FptF Are Highly Attenuated for Virulence and Are Protective Against Lethal Intranasal Francisella LVS Challenge in a Murine Model of Respiratory Tularemia
por: Hobbs, Brandi E., et al.
Publicado: (2021)

Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle
por: Freudenberger Catanzaro, Kelly C., et al.
Publicado: (2022)

Production of Anti-LPS IgM by B1a B Cells Depends on IL-1β and Is Protective against Lung Infection with Francisella tularensis LVS
por: del Barrio, Laura, et al.
Publicado: (2015)

Multiple T Cell Subsets Control Francisella tularensis LVS Intracellular Growth Without Stimulation Through Macrophage Interferon γ Receptors
por: Cowley, Siobhán C., et al.
Publicado: (2003)

IL-23 p19 Knockout Mice Exhibit Minimal Defects in Responses to Primary and Secondary Infection with Francisella tularensis LVS
por: Kurtz, Sherry L., et al.
Publicado: (2014)

Lack of OxyR and KatG Results in Extreme Susceptibility of Francisella tularensis LVS to Oxidative Stress and Marked Attenuation In vivo
por: Honn, Marie, et al.
Publicado: (2017)

Atg5-Deficient Mice Infected with Francisella tularensis LVS Demonstrate Increased Survival and Less Severe Pathology in Internal Organs
por: Kelava, Ina, et al.
Publicado: (2020)

PdpC, a secreted effector protein of the type six secretion system, is required for erythrocyte invasion by Francisella tularensis LVS
por: Cantlay, Stuart, et al.
Publicado: (2022)

Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirus-vectored vaccines
por: Zhao, Mengsu, et al.
Publicado: (2023)

Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles
por: Whelan, Adam O., et al.
Publicado: (2018)

The Reduced Genome of the Francisella tularensis Live Vaccine Strain (LVS) Encodes Two Iron Acquisition Systems Essential for Optimal Growth and Virulence
por: Pérez, Natalie Marie, et al.
Publicado: (2014)

Models Derived from In Vitro Analyses of Spleen, Liver, and Lung Leukocyte Functions Predict Vaccine Efficacy against the Francisella tularensis Live Vaccine Strain (LVS)
por: De Pascalis, Roberto, et al.
Publicado: (2014)

A human macrophage – hepatocyte co-culture model for comparative studies of infection and replication of Francisella tularensis LVS strain and subspecies holarctica and mediasiatica
por: Rennert, Knut, et al.
Publicado: (2016)

A ΔclpB Mutant of Francisella tularensis Subspecies holarctica Strain, FSC200, Is a More Effective Live Vaccine than F. tularensis LVS in a Mouse Respiratory Challenge Model of Tularemia
por: Golovliov, Igor, et al.
Publicado: (2013)

Francisella tularensis, Portugal
por: Lopes de Carvalho, Isabel, et al.
Publicado: (2007)

Etymologia: Francisella tularensis
por: Männikkö, Nancy
Publicado: (2011)

Metapopulation structure for perpetuation of Francisella tularensis tularensis
por: Goethert, Heidi K, et al.
Publicado: (2009)

Comparative review of Francisella tularensis and Francisella novicida
por: Kingry, Luke C., et al.
Publicado: (2014)

Use of a Capture-Based Pathogen Transcript Enrichment Strategy for RNA-Seq Analysis of the Francisella Tularensis LVS Transcriptome during Infection of Murine Macrophages
por: Bent, Zachary W., et al.
Publicado: (2013)

Characterization of lethal inhalational infection with Francisella tularensis in the common marmoset (Callithrix jacchus)
por: Nelson, Michelle, et al.
Publicado: (2010)

Respiratory Tularemia: Francisella Tularensis and Microarray Probe Designing
por: Ranjbar, Reza, et al.
Publicado: (2016)

Regulation of Francisella Tularensis Virulence
por: Dai, Shipan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bd4lfl0epos7uej7ir3q75n28o